Cargando…
Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study
BACKGROUND: COPD patients are more susceptible to viral respiratory infections and their sequelae, and have intrinsically weaker immune responses to vaccinations against influenza and other pathogens. Prime-boost, double-dose immunisation has been suggested as a general strategy to overcome weak hum...
Autores principales: | Anderson, Gary P., Irving, Louis B., Jarnicki, Andrew, Kedzierska, Katherine, Koutsakos, Marios, Kent, Stephen, Hurt, Aeron C., Wheatley, Adam K., Nguyen, Thi H.O., Snape, Natale, Upham, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986756/ https://www.ncbi.nlm.nih.gov/pubmed/36891079 http://dx.doi.org/10.1183/23120541.00641-2021 |
Ejemplares similares
-
Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people
por: Snape, Natale, et al.
Publicado: (2022) -
Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
por: Allen, Robert J., et al.
Publicado: (2017) -
Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
por: Liu, Yi, et al.
Publicado: (2019) -
Viral burden, inflammatory milieu and CD8(+) T‐cell responses to influenza virus in a second‐generation thiazolide (RM‐5061) and oseltamivir combination therapy study
por: Nüssing, Simone, et al.
Publicado: (2020) -
Influenza lineage extinction during the COVID-19 pandemic?
por: Koutsakos, Marios, et al.
Publicado: (2021)